Professional Documents
Culture Documents
Proposal For Multi Organ Transplant Centre
Proposal For Multi Organ Transplant Centre
Appendix I
Unit description Unit cost Number of units Costs
approximation required
Each OT (OT Table 2 crores 6 12 crores
with
lights, anaesthesia
workstation, cautery/
harmonic unit, self-
retaining retractor,
Laparoscopy station 80 lakhs 2 1.6 crores
Instrument sets 10 lakhs 36 3.6 crores
C arm (CATH LAB) 7 crores 1 7 crores
Scrub station 5 lakhs 3 15 lakhs
Sterilization unit 50 lakhs 3 1.5 crores
Ultrasound for OT 25 lakhs 2 50 lakhs
ROBOT (Da Vinci) 20 crores 1 20 crores
TEG/SONOCLOT 5 lakhs 1 5 lakhs
Auto pulse CPR 25 Lakhs 1 25 lakhs
TOTAL
46.65CRORES
Appendix II
Unit description
Pre-processing 1 crore 1 1 crore
equipment: centrifuge,
microscopes,
automated DNA/ RNA
isolators,
electrophoresis
Pathology laboratory: 50 lacs 3 1.5 crores
Microwave processing,
microscopy stations
Luminex platform 75 lacs 2 1.5 crores
Flow cytometer 1.5 crores 1 1.5 crores
HLA laboratory 1 crore 1 1 crore
RT-PCR 50 lacs 2 1 crore
LC-MS for therapeutic 1.5 crores 2 3 crores
drug monitoring
High throughput DNA 1.5 crores 1 1.5 crores
sequencer
TOTAL 12 CRORES
Unit description Unit cost Total required Costs
approximation
Beds with monitors 5 lakhs ICU: 12 2.2 crores
and furniture: HDU: 20
Cardiac table, side Isolation: 6
table, stools, IV Treatment rooms
stands, infusion and minor OTs: 6
pumps and fluid
warmer
General ward beds 2 lakhs General ward: 20 66 lakhs
Pvt room: 10
Recovery non
monitored beds: 3
Nursing staff
Post Annual costs Number of personnel Total costs
Staff nurse 4 lacs 170 6.8 crores
Technical staff
Clerical staff
Other staff
Drug monitoring: Kidney transplantation is considered the best treatment modality for
patients with kidney failure. Transplant recipients require lifelong immunosuppression.
Nowadays, most centres use triple immunosuppression, consisting of calcineurin inhibitor
(tacrolimus or cyclosporine), an antimetabolite (mycophenolate mofetil or azathioprine), and
corticosteroids. The calcineurin inhibitors form the backbone of present-day
immunosuppressive regimens and most centres worldwide have now shifted to tacrolimus-
based immunosuppression. For better graft and patient survival, it is essential to optimize
the degree of immunosuppression, as over-immunosuppression might lead to increase
adverse effects and under-immunosuppression predisposes to rejection. To achieve this
balance and to individualize drug dosing, therapeutic drug monitoring (TDM) of various
immunosuppressive drugs is required.